CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinasesBETTAYEB, K; OUMATA, N; ECHALIER, A et al.Oncogene (Basingstoke). 2008, Vol 27, Num 44, pp 5797-5807, issn 0950-9232, 11 p.Article

Cyclin D1 and cyclin D-dependent kinases enhance oral keratinocyte proliferation but do not block keratinocyte differentiationWOODS, Michael; PANT, Rima; MALLYA, Sanjay M et al.International journal of oncology. 2010, Vol 37, Num 6, pp 1471-1475, issn 1019-6439, 5 p.Article

Cyclin D1 and D3 expression in melanocytic skin lesionsALEKSEENKO, Ana; WOJAS-PELC, Anna; LIS, Grzegorz J et al.Archives of dermatological research (Print). 2010, Vol 302, Num 7, pp 545-550, issn 0340-3696, 6 p.Article

The cooperation of B-Myb with the coactivator p300 is orchestrated by cyclins A and D1SCHUBERT, Stephan; HORSTMANN, Sebastian; BARTUSEL, Thorsten et al.Oncogene (Basingstoke). 2004, Vol 23, Num 7, pp 1392-1404, issn 0950-9232, 13 p.Article

The sensitivity and specificity of a new formula to distinguish endometrioid type endometrial carcinoma from ovarian endometrial carcinomaNISHIMURA, Sadako; ITO, Yoichi M; HATAE, Masayuki et al.European journal of obstetrics, gynecology, and reproductive biology. 2010, Vol 148, Num 1, pp 67-72, issn 0301-2115, 6 p.Article

D cyclins in CD5+ B-cell lymphoproliferative disorders : Cyclin D1 and cyclin D2 identify diagnostic groups and cyclin D1 correlates with ZAP-70 expression in chronic lymphocytic leukemiaMEYERSON, Howard J; MACLENNAN, Grayden; HUSEL, William et al.American journal of clinical pathology. 2006, Vol 125, Num 2, pp 241-250, issn 0002-9173, 10 p.Article

Antitumor effects of vitamins K1, K2 and K3 on hepatocellular carcinoma in vitro and in vivoHITOMI, Misuzu; YOKOYAMA, Fumi; WATANABE, Seishiro et al.International journal of oncology. 2005, Vol 26, Num 3, pp 713-720, issn 1019-6439, 8 p.Article

Preclinical activity of P276-00, a novel small-molecule cyclin-dependent kinase inhibitor in the therapy of multiple myelomaRAJE, N; HIDESHIMA, T; KIZILTEPE, T et al.Leukemia. 2009, Vol 23, Num 5, pp 961-970, issn 0887-6924, 10 p.Article

Cyclin D1, cyclin E, and p21 have no apparent prognostic value in anal carcinomas treated by radiotherapy with or without chemotherapyALLAL, A. S; GERVAZ, P; BRÜNDLER, M-A et al.British journal of cancer. 2004, Vol 91, Num 7, pp 1239-1244, issn 0007-0920, 6 p.Article

Cyclin G2 Regulates Adipogenesis through PPARγ CoactivationAGUILAR, Victor; ANNICOTTE, Jean-Sébastien; ESCOTE, Xavier et al.Endocrinology (Philadelphia). 2010, Vol 151, Num 11, pp 5247-5254, issn 0013-7227, 8 p.Article

Cyclin-dependent kinase inhibition by the KLF6 tumor suppressor protein through interaction with cyclin D1BENZENO, Sharon; NARLA, Goutham; ALLINA, Jorge et al.Cancer research (Baltimore). 2004, Vol 64, Num 11, pp 3885-3891, issn 0008-5472, 7 p.Article

Expression of cyclins E, A, and B, and prognosis in lymph node-negative breast cancerKÜHLING, Heidi; ALM, Per; OLSSON, Halkan et al.Journal of pathology. 2003, Vol 199, Num 4, pp 424-431, issn 0022-3417, 8 p.Article

Loss of Cdk2 and Cyclin A2 Impairs Cell Proliferation and TumorigenesisGOPINATHAN, Lakshmi; SHAWN LU WEN TAN; PADMAKUMAR, V. C et al.Cancer research (Chicago, Ill.). 2014, Vol 74, Num 14, pp 3870-3879, issn 0008-5472, 10 p.Article

In vitro and In vivo pharmacokinetic-pharmacodynamic relationships for the trisubstituted aminopurine cyclin-dependent kinase inhibitors olomoucine, bohemine and CYC202RAYNAUD, Florence I; WHITTAKER, Steven R; VALENTI, Melanie et al.Clinical cancer research. 2005, Vol 11, Num 13, pp 4875-4888, issn 1078-0432, 14 p.Article

Cell cycle-regulatory cyclins and their deregulation in oral cancerMISHRA, Rajakishore.Oral oncology (1997). 2013, Vol 49, Num 6, pp 475-481, issn 1368-8375, 7 p.Article

A distinct type of cyclin D, CYCD4;2, involved in the activation of cell division in ArabidopsisKONO, Atsushi; OHNO, Ryoko; UMEDA-HARA, Chikage et al.Plant cell reports (Print). 2006, Vol 25, Num 6, pp 540-545, issn 0721-7714, 6 p.Article

Clinicopathologic significance and prognostic role of cyclin E and cyclin A expression in laryngeal epithelial lesionsFRACZEK, Marcin; WOZNIAK, Zbigniew; RAMSEY, David et al.Acta oto-laryngologica. 2008, Vol 128, Num 3, pp 329-334, issn 0001-6489, 6 p.Article

Roscovitine blocks leukocyte extravasation by inhibition of cyclin-dependent kinases 5 and 9BERBERICH, Nina; UHL, Bernd; JOORE, Jos et al.British journal of pharmacology. 2011, Vol 163, Num 5, pp 1086-1098, issn 0007-1188, 13 p.Article

Cell-specific responses to loss of cyclin-dependent kinasesBERTHET, C; KALDIS, P.Oncogene (Basingstoke). 2007, Vol 26, Num 31, pp 4469-4477, issn 0950-9232, 9 p.Article

Cyclin E in normal and neoplastic cell cyclesHWANG, Harry C; CLURMAN, Bruce E.Oncogene (Basingstoke). 2005, Vol 24, Num 17, pp 2776-2786, issn 0950-9232, 11 p.Article

Apogossypolone inhibits cell growth by inducing cell cycle arrest in U937 cellsJIAN SUN; LI, Zhi-Ming; HU, Zhe-Yu et al.Oncology reports. 2009, Vol 22, Num 1, pp 193-198, issn 1021-335X, 6 p.Article

Cyclin-dependent kinase (cdk6) and p16 in pancreatic endocrine neoplasmsTOMITA, Tatsuo.Pathology (Sydney). 2004, Vol 36, Num 6, pp 566-570, issn 0031-3025, 5 p.Article

Cyclin dependent kinase 2 and the regulation of human progesterone receptor activityMOORE, Nicole L; NARAYANAN, Ramesh; WEIGEL, Nancy L et al.Steroids. 2007, Vol 72, Num 2, pp 202-209, issn 0039-128X, 8 p.Conference Paper

Cdk6-cyclin D3 activity in murine ES cells is resistant to inhibition by p16^INK4aFAAST, Renate; WHITE, Josephine; CARTWRIGHT, Peter et al.Oncogene (Basingstoke). 2004, Vol 23, Num 2, pp 491-502, issn 0950-9232, 12 p.Article

Orphan Receptor Small Heterodimer Partner Suppresses Tumorigenesis by Modulating Cyclin Dl Expression and Cellular ProliferationYUXIA ZHANG; PING KU; PARK, Kyungtae et al.Hepatology (Baltimore, Md.). 2008, Vol 48, Num 1, pp 289-298, issn 0270-9139, 10 p.Article